Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$60.01
-6.4%		$46.59
$38.91
▼
$147.03
$1.73B0.71.17 million shs1.45 million shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$87.18
+1.6%		$70.72
$59.74
▼
$94.75
$5.21B0.48827,480 shs1.97 million shs
NovoCure Limited stock logo
NVCR
NovoCure
$16.05
-1.4%		$16.36
$9.82
▼
$21.45
$1.87B0.971.79 million shs1.23 million shs
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$10.42
-14.6%		$10.46
$8.85
▼
$16.99
$421.18M0.68336,470 shs1.19 million shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
+22.70%+23.38%+36.47%+39.73%-51.01%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+0.34%+9.62%+20.72%+39.25%+0.52%
NovoCure Limited stock logo
NVCR
NovoCure
+6.20%-0.25%-5.41%-1.39%+38.35%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-0.49%-0.49%+22.74%+0.08%+12.44%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$60.01
-6.4%		$46.59
$38.91
▼
$147.03
$1.73B0.71.17 million shs1.45 million shs
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$87.18
+1.6%		$70.72
$59.74
▼
$94.75
$5.21B0.48827,480 shs1.97 million shs
NovoCure Limited stock logo
NVCR
NovoCure
$16.05
-1.4%		$16.36
$9.82
▼
$21.45
$1.87B0.971.79 million shs1.23 million shs
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$10.42
-14.6%		$10.46
$8.85
▼
$16.99
$421.18M0.68336,470 shs1.19 million shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
+22.70%+23.38%+36.47%+39.73%-51.01%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+0.34%+9.62%+20.72%+39.25%+0.52%
NovoCure Limited stock logo
NVCR
NovoCure
+6.20%-0.25%-5.41%-1.39%+38.35%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-0.49%-0.49%+22.74%+0.08%+12.44%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.10
Hold$68.0013.32% Upside
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
2.73
Moderate Buy$100.3015.05% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.14
Hold$21.2032.09% Upside
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
2.40
Hold$16.0053.55% Upside

Current Analyst Ratings Breakdown

Latest OFIX, MMSI, NVCR, and INSP Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Weight
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$54.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold$54.00 ➝ $62.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Perform$60.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$75.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$55.00 ➝ $60.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$54.00 ➝ $60.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$55.00 ➝ $65.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$54.00 ➝ $59.00
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Oppenheimer Holdings, Inc. logo
Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$85.00
8/3/2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D+) ➝ Hold (C-)
(Data available from 8/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$911.98M1.90$3.29 per share18.23$26.88 per share2.23
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.58B3.30$5.99 per share14.55$28.13 per share3.10
NovoCure Limited stock logo
NVCR
NovoCure
$655.35M2.85N/AN/A$2.90 per share5.53
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
$822.31M0.51N/AN/A$11.30 per share0.92
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$145.42M$4.4913.3645.465.2915.03%8.86%7.56%N/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$128.49M$2.4236.0222.132.279.22%13.75%8.10%N/A
NovoCure Limited stock logo
NVCR
NovoCure
-$136.23M-$1.30N/AN/AN/A-21.25%-44.00%-15.85%N/A
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$92.19M-$1.51N/AN/AN/A-7.27%-13.44%-7.05%8/5/2026 (Confirmed)

Latest OFIX, MMSI, NVCR, and INSP Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$0.4099-$0.39+$0.0199-$0.39$209.28 million$210.93 million
8/3/2026Q2 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.2359$0.14+$0.3759$0.01$194.72 million$200.58 million
7/30/2026Q2 2026
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.9590$1.19+$0.2310$0.65$405.25 million$418.84 million
7/23/2026Q2 2026
NovoCure Limited stock logo
NVCR
NovoCure
-$0.3315-$0.13+$0.2015-$0.13$172.44 million$183.58 million
5/5/2026Q1 2026
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
-$0.68-$0.52+$0.16-$0.52$196.40 million$196.71 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
6.34
4.48
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.44
4.20
2.79
NovoCure Limited stock logo
NVCR
NovoCure
0.58
2.89
2.70
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
0.54
2.87
1.76

Institutional Ownership

CompanyInstitutional Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
89.76%

Insider Ownership

CompanyInsider Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.20%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.70%
NovoCure Limited stock logo
NVCR
NovoCure
6.55%
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
2.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,33328.81 million28.18 millionOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
7,50059.71 million59.29 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,605116.45 million108.82 millionOptionable
Orthofix Medical Inc. stock logo
OFIX
Orthofix Medical
1,60540.42 million39.33 millionOptionable

Recent News About These Companies

Orthofix: Q2 Earnings Snapshot
 |  houstonchronicle.comH
Orthofix Medical Inc. Q2 2026 Earnings Call Summary
 |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/orthofix-medical-inc-q2-2026-170644440.html
Orthofix forecasts $845M-$855M 2026 net sales, supported by $15M Europe MDR inventory order
 |  seekingalpha.comhttps://seekingalpha.com/news/4626088-orthofix-forecasts-845m-855m-2026-net-sales-supported-by-15m-europe-mdr-inventory-order
Orthofix Medical (NASDAQ:OFIX) Issues Quarterly Earnings Results
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/orthofix-medical-nasdaqofix-issues-quarterly-earnings-results-2026-08-05/
Orthofix Medical Q2 Earnings Call Highlights
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/orthofix-medical-q2-earnings-call-highlights-2026-08-05/
Bet on 5 Top-Ranked Stocks With Rising P/E
August 5 at 9:51 AM  |  zacks.comhttps://www.zacks.com/stock/news/2968617/bet-on-5-top-ranked-stocks-with-rising-p-e?cid=cs-stocknewsapi-ft-analyst_blog|rw-2968617
Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates
August 5 at 9:16 AM  |  zacks.comhttps://www.zacks.com/stock/news/2968321/orthofix-ofix-q2-earnings-and-revenues-surpass-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2968321
Orthofix Medical (OFIX) Expected to Post Quarterly Earnings on Wednesday
August 4 at 2:10 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30939204
Orthofix Medical (OFIX) Gets a Buy from Canaccord Genuity
July 29, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/OFIX/pressreleases/3181850/orthofix-medical-ofix-gets-a-buy-from-canaccord-genuity/
Orthofix Medical (OFIX) Receives a Buy from Barrington
July 29, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/OFIX/pressreleases/3160661/orthofix-medical-ofix-receives-a-buy-from-barrington/
Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for
July 29, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2963370/analysts-estimate-orthofix-ofix-to-report-a-decline-in-earnings-what-to-look-out-for?cid=cs-stocknewsapi-ft-tale_of_the_tape|yseop_template_9-2963370
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?
July 29, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/did-orthofix-medical-inc-insiders-breach-their-fiduciary-duties-to-shareholders-302837769.html
Orthofix Medical (OFIX) Projected to Post Earnings on Wednesday
July 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/orthofix-medical-ofix-projected-to-post-earnings-on-wednesday-2026-07-29/
Financial Survey: Intuitive Surgical (NASDAQ:ISRG) & Orthofix Medical (NASDAQ:OFIX)
July 29, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30927714
Engine Capital Management LP Acquires 137,858 Shares of Orthofix Medical Inc. $OFIX
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-engine-capital-management-lp-acquires-137858-shares-of-orthofix-medical-inc-ofix-2026-07-28/
Orthofix Medical Inc. (NASDAQ:OFIX) Receives Average Rating of "Hold" from Brokerages
July 28, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30925436
Orthofix Medical Inc. (NASDAQ:OFIX) Given Consensus Rating of "Hold" by Analysts
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/orthofix-medical-inc-nasdaqofix-given-consensus-rating-of-hold-by-analysts-2026-07-28/
Can Orthofix Medical (NASDAQ:OFIX) Capitalize on A Key Medicare Shift?
July 27, 2026  |  kalkinemedia.comK
Orthofix Medical (OFIX) Looks Attractive After CMS Reversed Its Reimbursement Cut
July 24, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/orthofix-medical-ofix-looks-attractive-160726620.html
Orthofix Medical (OFIX) Looks Attractive After CMS Reversed Its Reimbursement
July 23, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/orthofix-medical-ofix-looks-attractive-after-cms-reversed-its-reimbursement-cut-1803262/
Wall Street Analysts Think Orthofix (OFIX) Could Surge 33.28%: Read This Before Placing a Bet
July 22, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2958181/wall-street-analysts-think-orthofix-ofix-could-surge-33-28-read-this-before-placing-a-bet?cid=cs-stocknewsapi-ft-tale_of_the_tape|consensus_price_target-2958181

New MarketBeat Followers Over Time

Media Sentiment Over Time

Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$60.01 -4.13 (-6.45%)
Closing price 03:59 PM Eastern
Extended Trading
$60.14 +0.13 (+0.21%)
As of 04:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Merit Medical Systems stock logo

Merit Medical Systems NASDAQ:MMSI

$87.18 +1.36 (+1.58%)
Closing price 04:00 PM Eastern
Extended Trading
$87.10 -0.09 (-0.10%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$16.05 -0.22 (-1.35%)
Closing price 04:00 PM Eastern
Extended Trading
$16.05 0.00 (0.00%)
As of 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Orthofix Medical stock logo

Orthofix Medical NASDAQ:OFIX

$10.42 -1.78 (-14.59%)
Closing price 04:00 PM Eastern
Extended Trading
$11.28 +0.86 (+8.21%)
As of 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas